AAAAAA
Results:
1-12
|
Results: 12
Authors:
Zinzani, PL
Martelli, M
De Renzo, A
Zaccaria, A
Pavone, E
Bocchia, M
Falini, B
Gobbi, M
Gherlinzoni, F
Bendandi, M
Stefoni, V
Tani, M
Tura, S
Citation: Pl. Zinzani et al., Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy, HAEMATOLOG, 86(2), 2001, pp. 187-191
Authors:
Lauria, F
Lenoci, M
Annino, L
Raspadori, D
Marotta, G
Bocchia, M
Forconi, F
Gentili, S
La Manda, M
Marconcini, S
Tozzi, M
Baldini, L
Zinzani, PL
Foa, R
Citation: F. Lauria et al., Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia, HAEMATOLOG, 86(10), 2001, pp. 1046-1050
Authors:
Laszlo, D
Galieni, P
Raspadori, D
Scalia, G
Bigazzi, C
Bocchia, M
Bucalossi, A
Marotta, G
Tozzi, M
Lauria, F
Citation: D. Laszlo et al., "Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients", LEUK LYMPH, 37(1-2), 2000, pp. 157-161
Authors:
Marotta, G
Bigazzi, C
Lenoci, M
Tozzi, M
Bocchia, M
Lauria, F
Citation: G. Marotta et al., Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy, HAEMATOLOG, 85(12), 2000, pp. 1268-1270
Authors:
Bocchia, M
Bronte, V
Colombo, MP
De Vincentiis, A
Di Nicola, M
Forni, G
Lanata, L
Lemoli, RM
Massaia, M
Rondelli, D
Zanon, P
Tura, S
Citation: M. Bocchia et al., Antitumor vaccination: where we stand, HAEMATOLOG, 85(11), 2000, pp. 1172-1206
Authors:
Pinilla-Ibarz, J
Cathcart, K
Korontsvit, T
Soignet, S
Bocchia, M
Caggiano, J
Lai, L
Jimenez, J
Kolitz, J
Scheinberg, DA
Citation: J. Pinilla-ibarz et al., Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses, BLOOD, 95(5), 2000, pp. 1781-1787
Authors:
Bocchia, M
Bigazzi, C
Marconcini, S
Forconi, F
Marotta, G
Algeri, R
Lauria, F
Citation: M. Bocchia et al., Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas, HAEMATOLOG, 84(8), 1999, pp. 716-720
Authors:
Zinzani, PL
Martelli, M
Magagnoli, M
Zaja, F
Storti, S
Pavone, E
Lauta, VM
De Renzo, A
Gobbi, M
Bocchia, M
Ronconi, F
Scaramucci, L
Gherlinzoni, F
Palombi, F
Bendandi, M
Stefoni, V
Borza, PA
Cellini, C
Mandelli, F
Tura, S
Citation: Pl. Zinzani et al., How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens fare in the long-term?, HAEMATOLOG, 84(11), 1999, pp. 996-1001
Authors:
Zinzani, PL
Magagnoli, M
Moretti, L
Battista, R
Ronconi, F
De Renzo, A
Zaccaria, A
Gentilini, P
Guardigni, L
Gherlinzoni, F
Cellini, C
Fattori, PP
Bendandi, M
Bocchia, M
Aitini, E
Tura, S
Citation: Pl. Zinzani et al., Fludarabine based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients, HAEMATOLOG, 84(11), 1999, pp. 1002-1006
Authors:
Forconi, F
Bocchia, M
Marconcini, S
Bigazzi, C
Milani, M
Fraternali-Orcioni, G
Lauria, F
Citation: F. Forconi et al., CD30 positive (non-anaplastic) peripheral T cell lymphoma of the thyroid gland, HAEMATOLOG, 84(10), 1999, pp. 946-948
Authors:
Lauria, F
Bocchia, M
Marotta, G
Raspadori, D
Zinzani, PL
Rondelli, D
Citation: F. Lauria et al., Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications, HAEMATOLOG, 84(1), 1999, pp. 22-25
Authors:
Zinzani, PL
Storti, S
Zaccaria, A
Moretti, L
Magagnoli, M
Pavone, E
Gentilini, P
Guardigni, L
Gobbi, M
Fattori, PP
Falini, B
Lauta, VM
Bendandi, M
Gherlinzoni, F
De Renzo, A
Zaja, F
Mazza, P
Volpe, E
Bocchia, M
Aitini, E
Tabanelli, M
Leone, G
Tura, S
Citation: Pl. Zinzani et al., Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients, BLOOD, 94(1), 1999, pp. 33-38
Risultati:
1-12
|